GENEVA, March 3 -- ASTELLAS PHARMA INC. (5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo1038411), アステラス製薬株式会社 (東京都中央区日本橋本町二丁目５番１号) filed a patent application (PCT/JP2025/029107) for "USE OF ANTI-CLDN4/ANTI-CD137 BISPECIFIC ANTIBODY IN COMBINATION WITH PLATINUM-BASED DRUG FOR TREATMENT OF CANCER" on Aug 20, 2025. With publication no. WO/2026/042803, the details related to the patent application was published on Feb 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is mana...